Latest Coronavirus Disease COVID 19 News and Research
Why Black aging matters, too
Old. Chronically ill. Black. People who fit this description are more likely to die from COVID-19 than any other group in the country.
LA County authorities cautious despite declining COVID numbers
In Los Angeles County, California's main COVID-19 hot spot since early in the pandemic, key indicators of the disease have taken an encouraging turn recently.
Dozens of U.S. hospitals poised to defy FDA’s directive on COVID plasma
Dozens of major hospitals across the U.S. are grappling with whether to ignore a federal decision allowing broader emergency use of blood plasma from recovered COVID patients to treat the disease in favor of dedicating their resources to a gold-standard clinical trial that could help settle the science for good.
Improving COVID-19 Diagnosis
News-Medical spoke to Yourgene health on their efforts during the COVID-19 pandemic, and how they developed a diagnostic test for COVID-19.
New grant supports research into diabetic kidney disease and COVID-19
Mater and University of Queensland Researcher Dr Mitchell Sullivan has been awarded a 2020 Advance Queensland Industry Research Fellowship from the Queensland Government to fund his research into diabetic kidney disease and COVID-19.
Increased COVID-19 cases in India raise questions about reopening the economy
A spike in COVID-19 infections in India, reaching an average of more than 70,000 cases per day over the past week, has raised questions about reopening the economy, which contracted by 24 per cent of GDP as a result of a drastic national lockdown imposed in March to stop the virus from spreading.
_f54abc4842824939a0e276a764b4736f-150x125.jpg "Corticosteroids can be lifesaving for critically ill COVID-19 patients")
Corticosteroids can be lifesaving for critically ill COVID-19 patients
Now, a prospective meta-analysis of 7 randomized trials published in the journal JAMA showed that the widely available steroid drugs could help seriously ill patients survive COVID-19.
COVID-19 virus and antibodies can coexist in young patients, shows study
With many questions remaining around how children spread COVID-19, Children's National Hospital researchers set out to improve the understanding of how long it takes pediatric patients with the virus to clear it from their systems, and at what point they start to make antibodies that work against the coronavirus.
Reformulated generic drug could offer a cost-effective way to accelerate recovery, prevent hospitalizations
Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations.
Bioengineering technique that boosts protein production could lead to effective COVID-19 vaccine
A bioengineering technique to boost production of specific proteins could be the basis of an effective vaccine against the novel coronavirus that causes COVID-19, new research suggests.
Avacta enters into manufacturing agreement with Abingdon Health for rapid SARS-CoV-2 antigen test
Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.
Protocols for minimizing risk in COVID-19 bronchoscopy
One area, discussed in a recent paper by Northwestern University researchers and published on the preprint server medRxiv* in August 2020, is the viral exposure suffered by healthcare workers during bronchoalveolar lavage (BAL).
Researchers assess impact of coronavirus disease on individuals with progressive multiple sclerosis
Researchers conducting a large international study of progressive multiple sclerosis (MS) examined the impact of the global outbreak of coronavirus disease 2019 (COVID-19) on their study participants.
_db4cfde952e74a0593236fc8436f5cfa-150x125.jpg "Antibody responses in recovered COVID-19 individuals from India")
Antibody responses in recovered COVID-19 individuals from India
India has been hit hard by COVID-19, with at least 66,000 deaths and almost 4 million cases. The need to understand the infection, including the various antibody isotypes, and whether neutralizing antibodies and memory B cells are being produced, has driven much research into the way immunity is developing in Indian patients.
_42cf2e342cf0409f9016d7ffa985fd75-150x125.jpg "A global study to determine COVID-19 health and psychosocial consequences")
A global study to determine COVID-19 health and psychosocial consequences
The current paper lays out the details of a longitudinal study that aims to follow up COVID-19 patients, including any pre-existing chronic illnesses as well as the medical care they received during their illness. A significant minority of convalescents appears to have prolonged disease sequelae.
Major UK study launched to assess the impact of COVID-19 on cancer patients
A new UK study has been launched to assess the impact of covid-19 on people with cancer.
UC San Diego participates in second, massive clinical trial of COVID-19 vaccine
UC San Diego Health will be part of a second, massive clinical trial to assess the safety, efficacy and immunogenicity of a vaccine designed to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
Combined point-of-care nucleic acid and antibody testing increases COVID-19 detection
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease.
Researchers create new and quicker method of diagnosing diseases
A new and quicker method of diagnosing diseases in patients has been created by researchers at the University of Leeds.
Study shows SARS-CoV-2 jumps back and forth between animals and humans on mink farms
An in-depth investigation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks on 16 mink farms by researchers from the Netherlands revealed that minks might serve as a reservoir for persistent infection in humans. The study is currently available on bioRxiv* preprint server.
.png)
No hay comentarios:
Publicar un comentario